Israeli scientists are moving closer to a potential breakthrough in the treatment of severe spinal cord injuries. Researchers at Tel Aviv University, led by Professor Tal Dvir, have developed a technology for creating personalized spinal cord implants using a patient's own cells.
The innovative approach aims to restore damaged neural connections and may eventually help people who have lost the ability to walk following severe spinal cord injuries regain some motor function.
The technology, being developed in collaboration with the Israeli biotechnology company Matricelf, is advancing toward its first human clinical application. Subject to regulatory approval and the successful completion of the necessary studies, the first implantation could take place at Sheba Medical Center in Israel in 2027.
How Israeli Scientists Aim to Repair the Damaged Spinal Cord
Severe spinal cord injuries remain among the most challenging conditions in modern neurology and neurosurgery.
When nerve fibers within the spinal cord are damaged, communication between the brain and the body can be disrupted. Depending on the location and severity of the injury, patients may experience partial or complete paralysis, loss of sensation, and impaired bodily functions.
Current treatment and rehabilitation approaches focus on preventing complications, preserving remaining neurological function, improving mobility, and helping patients maintain the highest possible quality of life.
However, repairing damaged neural pathways and restoring lost neurological function remains a major medical challenge.
Researchers at Tel Aviv University are investigating a fundamentally different approach: creating living neural tissue implants from a patient's own cells.
The technology involves collecting patient-derived cells, reprogramming them into induced pluripotent stem cells (iPSCs), and using them to develop neural tissue suitable for implantation into the injured spinal cord.
The ultimate goal is to encourage the formation of new neural connections and potentially restore communication between the brain and the body.
Why Are the Implants Created From the Patient's Own Cells?
One of the most distinctive aspects of this Israeli technology is its personalized approach.
Instead of relying on donor tissue, researchers aim to produce biological implants using cells and tissue-derived materials obtained from the patient.
This strategy may offer several potential advantages:
- Reduced risk of immune rejection.
- Improved biological compatibility with the patient's tissues.
- Personalized implant development.
- Potential regeneration of damaged neural structures.
- New therapeutic possibilities for severe spinal cord injuries.
These benefits remain theoretical or supported by preclinical research. Their safety, effectiveness, and clinical significance must still be established through human studies.
First Human Trials Planned in Israel for 2027
The technology originated in the laboratory of Professor Tal Dvir at Tel Aviv University's Sagol Center for Regenerative Biotechnology.
Its further development is being carried out by the Israeli biotechnology company Matricelf, which specializes in personalized regenerative medicine technologies.
Several leading Israeli medical institutions are involved in preparations for the next stage of research.
Sheba Medical Center, Israel
Sheba Medical Center is expected to play a central role in the first clinical implantation and the evaluation of this experimental technology in humans.
Loewenstein Rehabilitation Medical Center, Israel
Loewenstein Rehabilitation Medical Center is involved in preparations for future clinical research, including the evaluation of potential candidates and the development of personalized treatment procedures.
According to preliminary plans, the first implantation may take place during the first half of 2027.
However, the timeline remains dependent on the completion of preclinical evaluations, confirmation of safety requirements, and final authorization from the Israeli Ministry of Health.
Could This Technology Help People With Paralysis Walk Again?
The primary objective of the research is to determine whether personalized spinal cord implants can support neural regeneration and improve motor function following severe spinal cord injuries.
If future clinical studies demonstrate positive results, the technology could potentially contribute to:
- Partial restoration of movement in the lower limbs.
- Improved transmission of nerve signals.
- Greater independence in everyday activities.
- Recovery of certain neurological functions.
- New rehabilitation opportunities for patients with severe spinal cord injuries.
It is important to emphasize that this technology remains experimental.
Although preclinical findings have been encouraging, its safety and effectiveness in humans have not yet been established.
The possibility of restoring walking ability remains a research objective rather than a clinically proven outcome.
Israel's Role in Advancing Regenerative Medicine
Israel has established a strong international presence in neuroscience, neurosurgery, biotechnology, and regenerative medicine research.
The development of personalized spinal cord implants highlights the importance of collaboration between academic research institutions, biotechnology companies, and major medical centers.
The project also demonstrates how advances in stem cell research and tissue engineering may contribute to future treatment strategies for conditions that currently have limited therapeutic options.
If upcoming clinical trials confirm the technology's safety and effectiveness, personalized neural implants could eventually become part of a new generation of treatments for severe spinal cord injuries.
Spinal Cord Injury Treatment and Rehabilitation in Israel
Sapir Medical Clinic assists international patients in accessing specialist consultations, diagnostic services, and treatment programs at leading medical institutions in Israel.
Patients living with spinal cord injuries, neurological damage, paralysis, or movement disorders may benefit from an expert medical assessment and a personalized rehabilitation strategy.
Sapir Medical Clinic can help international patients arrange:
- Consultations with Israeli neurologists and neurosurgeons.
- Second medical opinions regarding spinal cord injuries.
- Advanced neurological and spinal imaging.
- Orthopedic and neurosurgical evaluations.
- Medical rehabilitation consultations and treatment planning.
- Coordination of medical services in Israel.
Please note that the spinal cord implant described in this article is an experimental technology and is not currently available as an established treatment through Sapir Medical Clinic.
For information about specialist consultations, available diagnostic procedures, and treatment options in Israel, please contact our international patient coordinators.
Sapir Medical Clinic
Email: info@sapirmedical.com